With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Adele Viguera, MD, MPH, Assistant Professor of Psychiatry, Director of Clinical Research, Center for Women’s Mental Health, Cleveland Clinic, discusses pregnant women with bipolar disorder, which carries a…
NEW YORK (Reuters Health) – In the general population of patients with elevated blood pressure, there is currently no evidence to support aiming for a blood pressure (BP)…
NEW YORK (Reuters Health) – The American Society for Radiation Oncology (ASTRO) has released a consensus statement regarding patient selection and best practices in using accelerated partial breast…
NEW YORK (Reuters Health) – Contrary to common opinion, routine cervical screening can identify early-stage adenocarcinoma and adenosquamous carcinoma of the cervix, according to a large case-control study…
NEW YORK (Reuters Health) – Although the rate of hysterectomy after cesarean delivery has declined over the past decade, the procedure remains an “uncommon, but not rare” complication…
NEW YORK (Reuters Health) – Transvaginal sonography (TVS) is superior to symptom analysis for detecting ovarian cancer, while symptom analysis is better able to distinguish benign tumors, according…
NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased…
NEW YORK (Reuters Health) – Long-term strenuous activity may cut the risk of breast cancer in women, but may have a harmful effect on cognition, according to study…
July 14, 2009 (Portland, Ore.) – One in eight women develop breast cancer in their lifetimes. Although regular mammograms can reduce breast cancer deaths by more than 30…
NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the…
